AI assistant
Dr. Lal Pathlabs Limited — Call Transcript 2018
Nov 2, 2018
61783_rns_2018-11-02_f0293a02-ea10-4b64-982f-2d8bd62e3dfa.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [508 x 150] intentionally omitted <==
Conference Call Invitation
==> picture [224 x 72] intentionally omitted <==
12th Floor, Tower B, SAS Tower, Medicity, Sector-38, Gurgaon-122001, Haryana.
Q2 FY19 Earnings Conference Call Tuesday, November 6, 2018 at 04:30 pm IST
Gurgaon, November 2, 2018:
Dr. Lal PathLabs Ltd. (DLPL) will be hosting a conference call to discuss its Q2 FY19 results. DLPL will be represented by (Hony.) Brig. Dr. Arvind Lal - Chairman and Managing Director, Dr. Om Prakash Manchanda - Whole-time Director and CEO, Mr. Ved Goel - CFO. We would also have Mr. Bharath - Chief Operating Officer and Mr. Rajat Kalra - Company Secretary & Head of Investor Relations.
The conference call will be initiated with a brief discussion by the management on the Q2 FY19 financial and operating performance, which will be announced on the same day. Following this, there will be an opportunity for participants to get their queries addressed during the call.
Details of the conference call are as follows:
| Time | 04:30 pm IST on Tuesday, November 6, 2018 |
| Primary – +91 22 6280 1141Secondary – +91 22 7115 8042 | |
| Universal Access | |
| +91-7045671221Available all over India. | |
| Local Access | |
| USA – 18667462133 | |
| UK – 08081011573 | |
| Conference dial-inInternational Toll Number | |
| Singapore – 8001012045 | |
| Hong Kong – 800964448 | |
| +91 22 7194 5757 / +91 22 6663 575771837 (passcode)Valid from November 06, 2018 to November 13, 2018 | |
| Replay | |
-ENDS-
Dr. Lal PathLabs Q2 FY19 concall invitation
About Dr. Lal PathLabs Limited (DLPL)
Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are aimed at individual patients, hospitals and other healthcare providers and corporates. The catalogue of services* includes 1,110 test panels, 2,028 pathology tests and 1,561 radiology and cardiology tests.
As on March 31, 2018 DLPL’s has 193 clinical labs (including National Reference Lab at Delhi), 2,153 Patient Service Centers (PSCs) and 5,624 Pick-up Points (PUPs). In FY17 & FY18, DLPL collected and processed approximately 29.3 million samples and 34.7 million samples from approximately 13.3 million and 15.2 million patients, respectively.
Additional information on Dr. Lal PathLabs Limited: Corporate Identification No: L74899DL1995PLC065388 Website: https://www.lalpathlabs.com/ *As on 31st March, 2017
For further information please contact:
Ved Goel / Rajat Kalra Siddharth Rangnekar / Nishid Solanki Dr. Lal PathLabs Limited CDR India Tel: +91 124 301 6500 Tel: +91 22 66451209 / 1221 Fax: +91 124 423 4468 Fax: +91 22 66451213 E-mail: [email protected] Email: [email protected] [email protected] [email protected]
Dr. Lal PathLabs Q2 FY19 concall invitation